Clinical Trial Update: Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography [NA]

View source ↗

Summary

Clinical trial update reporting results of dexamethasone effects in patients with refractory non-small cell lung cancer, assessed using FLT PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer | NA | Status: COMPLETED | Results posted: 2025-08-22